# FreeCast, Inc.: financial statements, quarterly

CAST · Nasdaq · CIK 1633369 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/cast.md) · [Financials](/companies/cast/financials.md) · [Filings](/companies/cast/filings.md) · [Insiders](/companies/cast/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cast/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | [152](/filings/0001213900-26-038786.md) | [144](/filings/0001213900-26-056942.md) | [214 d](/filings/0001213900-26-104155.md) | not reported | [62.1](/filings/0001213900-26-038786.md) | [92.9](/filings/0001213900-26-056942.md) | [360 d](/filings/0001213900-26-104155.md) |
| Cost of revenue | $k | not reported | [73.9](/filings/0001213900-26-038786.md) | [93.7](/filings/0001213900-26-056942.md) | [76.7 d](/filings/0001213900-26-104155.md) | not reported | [39.6](/filings/0001213900-26-038786.md) | [34.4](/filings/0001213900-26-056942.md) | [1.4 d](/filings/0001213900-26-104155.md) |
| Gross profit | $k | not reported | [77.6](/filings/0001213900-26-038786.md) | [50.2](/filings/0001213900-26-056942.md) | [138 d](/filings/0001213900-26-104155.md) | not reported | [22.5](/filings/0001213900-26-038786.md) | [58.5](/filings/0001213900-26-056942.md) | [359 d](/filings/0001213900-26-104155.md) |
| Operating income | $k | not reported | [(3,887)](/filings/0001213900-26-038786.md) | [(3,307)](/filings/0001213900-26-056942.md) | [(3,050) d](/filings/0001213900-26-104155.md) | not reported | [(2,750)](/filings/0001213900-26-038786.md) | [(4,422)](/filings/0001213900-26-056942.md) | [(2,699) d](/filings/0001213900-26-104155.md) |
| Net income | $k | [(3,560)](/filings/0001213900-26-056942.md) | [(3,930)](/filings/0001213900-26-056942.md) | [(3,381)](/filings/0001213900-26-056942.md) | [(3,196) d](/filings/0001213900-26-104155.md) | [(2,862)](/filings/0001213900-26-056942.md) | [(2,784)](/filings/0001213900-26-056942.md) | [(4,534)](/filings/0001213900-26-056942.md) | [(2,864) d](/filings/0001213900-26-104155.md) |
| Diluted EPS | $ per share | not reported | [(0.10)](/filings/0001213900-26-038786.md) | [(0.09)](/filings/0001213900-26-056942.md) | not reported | not reported | [(0.07)](/filings/0001213900-26-038786.md) | [(0.11)](/filings/0001213900-26-056942.md) | not reported |
| Basic EPS | $ per share | not reported | [(0.10)](/filings/0001213900-26-038786.md) | [(0.09)](/filings/0001213900-26-056942.md) | not reported | not reported | [(0.07)](/filings/0001213900-26-038786.md) | [(0.11)](/filings/0001213900-26-056942.md) | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [0.5](/filings/0001213900-26-104155.md) | not reported | [0.4](/filings/0001213900-26-038786.md) | [0.1](/filings/0001213900-26-056942.md) | [8.9](/filings/0001213900-26-104155.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [0.9](/filings/0001213900-26-104155.md) | not reported | [0.7](/filings/0001213900-26-038786.md) | [0.6](/filings/0001213900-26-056942.md) | [9.4](/filings/0001213900-26-104155.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [1.4](/filings/0001213900-26-104155.md) | not reported | [1.2](/filings/0001213900-26-038786.md) | [1.1](/filings/0001213900-26-056942.md) | [9.9](/filings/0001213900-26-104155.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [6.0](/filings/0001213900-26-104155.md) | not reported | [4.5](/filings/0001213900-26-038786.md) | [7.9](/filings/0001213900-26-056942.md) | [7.5](/filings/0001213900-26-104155.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [6.2](/filings/0001213900-26-104155.md) | not reported | [4.8](/filings/0001213900-26-038786.md) | [8.1](/filings/0001213900-26-056942.md) | [7.6](/filings/0001213900-26-104155.md) |
| Shareholders' equity | $m | [(118)](/filings/0001213900-26-104155.md) | [(121)](/filings/0001213900-26-056942.md) | [(1.1)](/filings/0001213900-26-056942.md) | [(3.3)](/filings/0001213900-26-056942.md) | [(4.9)](/filings/0001213900-26-104155.md) | [(0.9)](/filings/0001213900-26-056942.md) | [(3.5)](/filings/0001213900-26-056942.md) | [(7.0)](/filings/0001213900-26-056942.md) | [2.3](/filings/0001213900-26-104155.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(3,295) d](/filings/0001213900-26-056942.md) | [(2,374) d](/filings/0001213900-26-104155.md) | [(2,851) d](/filings/0001213900-26-056942.md) | [(1,946) d](/filings/0001213900-26-104155.md) |
| Capital expenditure | $k | [(0.0) d](/filings/0001213900-26-056942.md) | [5.3 d](/filings/0001213900-26-104155.md) | [7.5 d](/filings/0001213900-26-056942.md) | [7.1 d](/filings/0001213900-26-104155.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [39.2](/filings/0001213900-26-038786.md) | [39.6](/filings/0001213900-26-056942.md) | [40.5](/filings/0001213900-26-038786.md) | [40.9](/filings/0001213900-26-056942.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.